Following the much anticipated approval of Europe's first gene therapy late last year, a decade after the first approval of such therapies in China, the world awaits a similar move...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)